Journal of Global Pharma Technology
Volume 11 Issue 2: 2019

Investigation of Tumor Necrosis Factor-Alpha (TNF A) Gene Polymorphism in Patients with Hypertension in Al-Diwaniyah City, Iraq

Ghaidaa Raheem Lateef Al-Awsi (Unknown)



Article Info

Publish Date
16 Nov 2016

Abstract

A study was conducted on 100 in the outpatient whom consulted Al-Diwaniyah Teaching Hospital in Al-Diwaniyah City in the period between October 2017 to April 2018.One hundred blood samples (50 experimental and 50 controls) were collected under the supervision of the treating physician. TNF-α, which is an abbreviation of “tumor necrosis factor alpha”, is one of the key distinctive pro-inflammatory cytokines emerging evidence have confirmed the vital role of TNF-α in the progress of hypertension. The genotyping regarding (TNF a) were carried out through utilizing polymerase chain reaction, commonly denoted as (PCR), along with (RFLP), which is an abbreviation of “restriction fragment length polymorphism”. We aimed at determined vital variations within the genotype frequencies of (TNF a) among control and experimental sample groups.Keywords: Hypertension, RFLP, TNF A, SNPs. Polymorphisms, Diwaniyah, Iraq

Copyrights © 2019






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...